Literature DB >> 10644102

Multicentric and multifocal cancer: whole-breast US in preoperative evaluation.

W A Berg1, P L Gilbreath.   

Abstract

PURPOSE: To evaluate preoperative whole-breast ultrasonography (US) in the management of breast cancer.
MATERIALS AND METHODS: The ipsilateral breast in 40 patients with known breast cancer or in whom there was high suspicion of breast cancer was evaluated with whole-breast US. Biopsy was performed on all discrete solid lesions.
RESULTS: US depicted 45 (94%) of 48 invasive tumor foci and seven (44%) of 16 foci of ductal carcinoma in situ (DCIS). Mammography depicted 39 (81%) of 48 invasive tumor foci and 14 (88%) of 16 foci of DCIS. The nine (14%) of 64 malignant foci seen only at US included three infiltrating ductal carcinomas, two mixed infiltrating and intraductal carcinomas, two infiltrating lobular carcinomas, and two foci of DCIS. Two (18%) of 11 foci of infiltrating lobular carcinoma were missed at both US and mammography. Of 20 patients mammographically suspected of having unifocal disease, three (15%) required wider excision on the basis of US findings. Two additional foci were depicted only at US in one of 16 patients mammographically suspected of having multicentric or multifocal disease. Of four patients with mammographically occult disease, US correctly depicted the diffuse (n = 2) or unifocal (n = 2) extent of the cancer.
CONCLUSION: Whole-breast US complements mammography in the preoperative evaluation of patients with breast cancer, particularly when breast conservation is contemplated.

Entities:  

Mesh:

Year:  2000        PMID: 10644102     DOI: 10.1148/radiology.214.1.r00ja2559

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

Review 1.  Integration of breast imaging into cancer management.

Authors:  L J Esserman; D Wolverton; N Hylton
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast.

Authors:  V Londero; C Zuiani; A Furlan; J Nori; M Bazzocchi
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

Review 3.  Incorporating new imaging models in breast cancer management.

Authors:  Denise H Reddy; Ellen B Mendelson
Journal:  Curr Treat Options Oncol       Date:  2005-03

4.  Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer.

Authors:  H J Shin; H H Kim; M O Huh; M J Kim; A Yi; H Kim; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-08-03       Impact factor: 3.039

5.  The Yield of Pre-operative Breast MRI in Patients According to Breast Tissue Density.

Authors:  Jean M Seely; Leslie Lamb; Neera Malik; Jacqueline Lau
Journal:  Eur Radiol       Date:  2015-11-30       Impact factor: 5.315

6.  The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Authors:  Kari M Rosenkranz; Karla Ballman; Linda McCall; Charlotte Kubicky; Laurie Cuttino; Huong Le-Petross; Kelly K Hunt; Armando Giuliano; Kimberly J Van Zee; Bruce Haffty; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2018-07-09       Impact factor: 5.344

7.  Role of Breast Ultrasound for the Detection and Differentiation of Breast Lesions.

Authors:  Helmut Madjar
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

8.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

9.  Sonomammographic characteristics of invasive lobular carcinoma.

Authors:  Osama R Kombar; Dalia M Fahmy; Mary V Brown; Omar Farouk; Osama El-Damshety
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-07-30

10.  Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.

Authors:  Richard G Barr; Zheng Zhang; Jean B Cormack; Ellen B Mendelson; Wendie A Berg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.